Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
10/2007
10/11/2007US20070238729 Dna-pk inhibitors
10/11/2007CA2647811A1 Substituted bicyclic derivative and use thereof
10/11/2007CA2647586A1 Process for producing 3-[4-(1,1-dimethyl-propyl)-phenyl]-2-methyl-propionaldehyde and cis-4-{3-[4-(1,1-dimethyl-propyl)-phenyl]-2-methyl-propyl}-2,6-dimethyl-morpholine (amorolfine)
10/10/2007EP1842848A1 Process for producing 3-[4-(1,1-dimethyl-propyl)-phenyl]2-methyl-propionaldehyde and cis-4{3-[4-(1,1-dimethyl-propyl)-phenyl]2-methyl-propyl}-2,6-dimethyl-morpholine (amorolfine)
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279573 Benzodiazepine derivatives that may be fused to a pyrroline or piperidine ring; e.g., N-[1 (R)-(3-Aminopropylcarbamoyl)-2-(naphthalen-2-yl)ethyl]-3-(5,11-dioxo-2,3-dihydro-1H-(11aS)-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)propionamide; increasing levels of endogenous growth hormones in humans and animals
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/04/2007US20070232601 Vla-4 Inhibitor
10/04/2007US20070232599 Muscarinic Acetylcholine Receptor Antagonists
10/03/2007EP1838664A1 Manufacture process of n-substituted salicylamides
10/03/2007EP1838296A2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
10/03/2007CN101048393A Substituted N-arylsulfonylheterocyclic amines as gamma-secretase inhibitors
10/03/2007CN100340552C Process for preparing aryl ether
10/02/2007US7276613 G protein coupled receptor antagonists with higher enzyme resistance than anandamide; amido, (dithio)carbamate, and (thio)urea analogs; antiepileptic agents, analgesics, antiemetics, immunosuppressants, anorexigenic agents; glaucoma
10/02/2007US7276610 Aryl piperidine amides
09/2007
09/27/2007WO2007109289A1 Enantiomerically pure s-etifoxine, pharmaceutical compositions thereof and methods of their use
09/27/2007WO2007109288A2 Enantiomerically pure r-etifoxine, pharmaceutical compositions thereof and methods of their use
09/27/2007US20070225495 N4-(2,2-Dimethyl-3-oxo-4H-5-pyrid[1,4]oxazin-6-yl)-N2-(3-chloro-4-methoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for IgE (Fc epsilon RI) and IgG (Fc gamma RI) antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis
09/27/2007US20070225288 Indene Derivatives and Process for the Preparation Thereof
09/27/2007US20070225281 6-Amino-1,4-dihydro-benzo[d][1,3]oxazin-2-ones and analogs useful as progesterone receptor modulators
09/27/2007US20070225267 beta -secretase inhibitors such as N-{(1S,2S)-1-(3,5-Difluorobenzyl)-2-[(3R,5S,6R)-6-(2,2-dimethylpropoxy)-5-methylmorpholin-3-yl]-2-hydroxyethyl}-acetamide, used for the treatment of neurodegenerative disorders such as Alzheimer's disease
09/27/2007US20070220688 Alpha-Hydroxy-Benzeneacetic Acid Derivatives, and Compounds Having Two 5-Membered Latone Rings Fused to Central Cyclohexa-1,4-Diene Nucleus Based Upon the Same, and Uses of the Compounds
09/27/2007CA2646007A1 Enantiomerically pure s-etifoxine, pharmaceutical compositions thereof and methods of their use
09/26/2007EP1836150A1 Hydroxyphenol derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof
09/26/2007CN101041669A Non nucleoside reverse transcriptase inhibitors
09/26/2007CN101041644A Preparation method of benzoxazine intermediate containing active function groups
09/25/2007US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents
09/25/2007US7273856 Antagonist of tachykinins like neurokinins and drugs
09/25/2007CA2230199C Pyridazin-3-one derivatives, their use as a herbicide, and intermediates for their production
09/20/2007WO2007105650A1 4-hydroxyisoleucine derivative and process for producing the derivative
09/20/2007WO2007104582A1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
09/20/2007US20070219343 Isobenzoxazinones And Their Use As Ultraviolet Light Absorbers
09/20/2007US20070219194 Phenylalanine derivatives
09/20/2007US20070219189 Mif-inhibitors
09/20/2007CA2637597A1 Tetrahydronaphthalene derivatives, processes for preparing them and their use as anti-inflammatory agents
09/19/2007CN100338071C New benzo-oxazino-isoindole derivatives, useful for treating cancers, are inhibitors of the cell cycle
09/18/2007US7271252 Immunogenic label for detection of low concentrations of viral therapeutics/antibodies in blood; diagnosing/detecion/monitoring viral drug resistance; immunoassay
09/18/2007US7270857 Liquid crystal composition and liquid crystal element
09/18/2007CA2177143C Metal chelate containing compositions for use in chemiluminescent assays
09/13/2007US20070213526 5-(2-thioxospiro[cyclohexane-1,3-[3H]-indol]-1-methyl-2-pyrrole-2-carbonitrile; treating with base in presence of solvent to form basic salt and converting it to purified form by treating with water, acid, or heat
09/13/2007US20070213364 Alkoxyphenylpropanoic Acid Derivatives
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/12/2007EP1831157A2 Nonnucleoside inhibitors of hiv-1 reverse transcriptase
09/12/2007EP0994867B1 Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine
09/12/2007CN101035782A Mif-inhibitors
09/12/2007CN101035776A Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments
09/11/2007US7268220 Chelation compounds, radionuclide metal chelate compounds (i.e., complexes) and radiolabeled targeting moieties (i.e., conjugates) formed therefrom, and methods of making and using these compounds, complexes and conjugates for diagnostic and therapeutic purposes
09/11/2007US7268149 Cyclothiocarbamate derivatives as progesterone receptor modulators and methods of treating skin disorders
09/11/2007US7268131 Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
09/07/2007WO2007099828A1 Nirogenous heterocyclic derivatives substituted with cyclic groups
09/07/2007WO2007099048A2 Use of polynuclear phenolic compounds as stabilisers
09/07/2007CA2641399A1 Use of polynuclear phenolic compounds as stabilisers
09/05/2007EP1829544A1 Pharmaceutically active morpholinol
09/05/2007EP1828150A2 Processes for producing 4-aminoquinazolines
09/05/2007EP1827446A2 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
09/05/2007EP1689698A4 Bis-cationic compounds and use thereof
09/05/2007CN101031554A Benzoxazine and quinoxaline derivatives and uses
09/05/2007CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods
09/04/2007US7265230 Herbicides
09/04/2007US7265130 anti-obestic activity; Neuropeptide Y antagonist
09/04/2007US7265110 Psychological disorders; antidepressants; anxiolytic agents; analgesics; antiinflammatory agents; central nervous system disorders
08/2007
08/30/2007WO2007054484A8 Process for the preparation of betamimetic benzoxazinone derivatives
08/30/2007US20070203139 Aryl Glycinamide Derivatives And Their Use As Nk1 Antagonists And Serotonin Reuptake Inhibitors
08/29/2007EP1694656B1 Benzoxazine derivatives and uses thereof
08/29/2007EP1549643B1 Method for preparing fused oxazinones from ortho-amino aromatic carboxylic acid and a carboxylic acid in the presence of a sulfonyl chloride and pyridine
08/29/2007CN101024633A Tricyclic arylamine monomer and polymers and devices thereof
08/28/2007US7262296 Substituted aryl alkenoic acid heterocyclic amides
08/28/2007US7262295 Wear resistance coating containing photochromic compound and polymer
08/28/2007US7262294 Wear resistance and high colourability characteristics; for use in paints, lacquers, paints or lacquers based on hybrid polysiloxanes and/or silica gel, plastics
08/28/2007US7262156 1-Oxazolidin-3-yl-3-(o-amino- or hydroxyphenyl-propenone derivatives, e.g., 1-[2-(2,4-Dimethyl-cyclohex-3-enyl)-oxazolidin-3-yl]-3-(2-hydroxy-phenyl)-propenone; for use in laundry detergents, perfumes, shampoos, and hair conditioners
08/28/2007US7261952 Red color emitting compounds for organic electroluminescent device and an organic electroluminescent device using them
08/28/2007US7261844 Photochromic contact lens having excellent discoloring characteristic
08/23/2007WO2007094022A1 Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenone
08/23/2007WO2007093507A1 Heterobicyclic sulfonamide derivatives for the treatment of diabetes
08/23/2007WO2007014154A3 10-substituted tetracyclines and methods of use thereof
08/23/2007US20070197523 Calcium channel antagonists
08/23/2007US20070197520 Mineralocorticoid receptor modulator compounds, processes for their preparation, and their uses
08/23/2007US20070197512 Carboxylic Acid Compounds and Use Thereof
08/23/2007US20070195309 Photochromic probes
08/23/2007CA2641440A1 Process for the preparation of 2-(4-hydroxy-3-morfolynil)-2-cyclohexenone
08/22/2007CN1332962C Method of synthesizing methanesulfonic acid parzhushaxing intermedinte
08/21/2007US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
08/21/2007US7259155 Phosphonic diester derivatives
08/16/2007WO2007091009A2 Preparation of delmopinol
08/16/2007WO2007011065A3 Intermediate compound for synthesizing pharmaceutical agent and production method thereof
08/16/2007US20070191603 Novel bicyclic sulfonamide derivatives which are L-CPT1 inhibitors
08/16/2007US20070191356 Pyridobenzoxazine derivative
08/16/2007US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds
08/15/2007EP1322596B1 Zwitterionic tachykinin receptor antagonists
08/14/2007US7256197 Methods for synthesis of diarylmethanes
08/14/2007US7256191 Materials and methods for the treatment of depression
08/09/2007WO2007089034A1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
08/09/2007US20070185101 Anthelmintics, ectoparasiticides, insecticides, acaricides; for humans/animals health and in agriculture; 2-(acetyloxy)-8a-hydroxy-3,8-dimethyl-5-(1-methylethyl)-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl-6-chloro-9b-hydroxy-5-methyl-1,2,3,3a,5,9b-hexahydropyrrolo[2,3-c][2,1]benzoxazine-2-carboxylate
08/08/2007CN1330614C Diphenyl anthracene derivate and organic electroluminescent apparatus using diphenyl anthracene derivate
08/08/2007CN101014580A Morpholine compound
08/07/2007US7253172 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
08/02/2007WO2007086504A1 Carboxylic acid compound and use thereof
08/02/2007WO2007070760A3 Compounds which modulate the cb2 receptor
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 112